Ann: US FDA Grants Approval for APAS-LBT.AX, page-688

just reading through the annual report (Sept 2016), apologies if this has already been posted but I found these parts particularly exciting with regards to future prospects (note I've listed them in order of lifecycle maturity:

Microstreak - "The Company is also in discussion with several companies on the licencing or sale of the MicroStreak technology."

and

APAS - "CCS is currently in discussions with an international diagnostics company to form an alliance to provide a range of APAS laboratory automation products."

lastly

Woundvue - "Proposals have been received for product development projects for WoundVue. These were sourced from two internationally recognised design engineering companies who were invited to submit their project plans and costings, including interest in risk-sharing and partnering.

A research program is in progress in collaboration with the Australian Centre for Visual Technology (ACVT) at the University of Adelaide. This should be completed by April 2017 with the finalisation of a Concept Development Prototype (CDP). The Company is investigating potential partnering opportunities and the necessary funding strategy to achieve full product development."

So effectively 3 irons in the fire, all at different stages of life cycle. Commercialisation of APAS however is the clear priority post FDA approval.

I also note Lusia Guthrie (LBT ex-CEO) has been appointed as Chairman of Clever Culture Systems AG (CCS), the joint venture company set up with Swiss company Hettich AG to develop and commercialise APAS. Looking at company filings, she has plenty of skin in the game with over 6m shares via direct and indirect holdings.

Always good news when those charged with delivering results have plenty of their own $$$ at stake.

Anyway, i'm sure this has all been covered in detail numerous times, but for any other new holders I would recommend you read the shareholders report on their website to get up to speed with the company and where it is going.

http://www.lbtinnovations.com/assets/Uploads/28-Sep-2016-Annual-report-to-shareholders.pdf